α2-Adrenoreceptor subtypes regulate ACTH and β-endorphin secretions during stress in the rat

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The effect of different α2-adrenoreceptor subtype agonists and antagonists on adrenocorticotrop hormone (ACTH) and β-endorphin release induced by ether stress was examined. Ether inhalation-induced ACTH and β- endorphin increase was inhibited by ICV administration of 30 μg but not 1 and 10 μg clonidine (α2-adrenoreceptor agonist). ICV oxymetazoline (α(2A)-adrenoreceptor agonist; 1-10-30 μg) or the α1-agonist methoxamine (100 μg/rat) failed to inhibit the stress-induced rise. Pretreatment with the α12(2B,C)-antagonist prazosin (0.5 mg/kg, IP) prevented the effect of clonidine on the ether stress, while the α1/α(2A)-antagonist WB-4101 (0.5 mg/kg, IP) was unable to counteract the inhibitory effect of clonidine. Prazosin alone had no effect on the ether-induced plasma ACTH and β- endorphin elevation. These results suggest that noradrenaline in the central nervous system may inhibit the stress-induced hypothalamo-pituitary-axis and pituitary β-endorphin activation via α(2B,C)-adrenoceptor subtypes and prazosin may antagonize its effect on these receptors.

Original languageEnglish
Pages (from-to)333-343
Number of pages11
JournalPsychoneuroendocrinology
Volume24
Issue number3
DOIs
Publication statusPublished - Apr 1999

Fingerprint

Endorphins
Ether
Prazosin
Clonidine
Hormones
Oxymetazoline
Methoxamine
Adrenergic Receptors
Inhalation
Norepinephrine
Central Nervous System

Keywords

  • Clonidine
  • Ether stress
  • Methoxamine
  • Oxymctazoline
  • Prazosin
  • WB-4101

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Psychiatry and Mental health
  • Biological Psychiatry
  • Endocrine and Autonomic Systems
  • Psychology(all)

Cite this

α2-Adrenoreceptor subtypes regulate ACTH and β-endorphin secretions during stress in the rat. / Zelena, D.; Kiem, Do T.; Barna, I.; Makara, G.

In: Psychoneuroendocrinology, Vol. 24, No. 3, 04.1999, p. 333-343.

Research output: Contribution to journalArticle

@article{015542f6fef34b82b945259b57ef708d,
title = "α2-Adrenoreceptor subtypes regulate ACTH and β-endorphin secretions during stress in the rat",
abstract = "The effect of different α2-adrenoreceptor subtype agonists and antagonists on adrenocorticotrop hormone (ACTH) and β-endorphin release induced by ether stress was examined. Ether inhalation-induced ACTH and β- endorphin increase was inhibited by ICV administration of 30 μg but not 1 and 10 μg clonidine (α2-adrenoreceptor agonist). ICV oxymetazoline (α(2A)-adrenoreceptor agonist; 1-10-30 μg) or the α1-agonist methoxamine (100 μg/rat) failed to inhibit the stress-induced rise. Pretreatment with the α1/α2(2B,C)-antagonist prazosin (0.5 mg/kg, IP) prevented the effect of clonidine on the ether stress, while the α1/α(2A)-antagonist WB-4101 (0.5 mg/kg, IP) was unable to counteract the inhibitory effect of clonidine. Prazosin alone had no effect on the ether-induced plasma ACTH and β- endorphin elevation. These results suggest that noradrenaline in the central nervous system may inhibit the stress-induced hypothalamo-pituitary-axis and pituitary β-endorphin activation via α(2B,C)-adrenoceptor subtypes and prazosin may antagonize its effect on these receptors.",
keywords = "Clonidine, Ether stress, Methoxamine, Oxymctazoline, Prazosin, WB-4101",
author = "D. Zelena and Kiem, {Do T.} and I. Barna and G. Makara",
year = "1999",
month = "4",
doi = "10.1016/S0306-4530(98)00081-X",
language = "English",
volume = "24",
pages = "333--343",
journal = "Psychoneuroendocrinology",
issn = "0306-4530",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - α2-Adrenoreceptor subtypes regulate ACTH and β-endorphin secretions during stress in the rat

AU - Zelena, D.

AU - Kiem, Do T.

AU - Barna, I.

AU - Makara, G.

PY - 1999/4

Y1 - 1999/4

N2 - The effect of different α2-adrenoreceptor subtype agonists and antagonists on adrenocorticotrop hormone (ACTH) and β-endorphin release induced by ether stress was examined. Ether inhalation-induced ACTH and β- endorphin increase was inhibited by ICV administration of 30 μg but not 1 and 10 μg clonidine (α2-adrenoreceptor agonist). ICV oxymetazoline (α(2A)-adrenoreceptor agonist; 1-10-30 μg) or the α1-agonist methoxamine (100 μg/rat) failed to inhibit the stress-induced rise. Pretreatment with the α1/α2(2B,C)-antagonist prazosin (0.5 mg/kg, IP) prevented the effect of clonidine on the ether stress, while the α1/α(2A)-antagonist WB-4101 (0.5 mg/kg, IP) was unable to counteract the inhibitory effect of clonidine. Prazosin alone had no effect on the ether-induced plasma ACTH and β- endorphin elevation. These results suggest that noradrenaline in the central nervous system may inhibit the stress-induced hypothalamo-pituitary-axis and pituitary β-endorphin activation via α(2B,C)-adrenoceptor subtypes and prazosin may antagonize its effect on these receptors.

AB - The effect of different α2-adrenoreceptor subtype agonists and antagonists on adrenocorticotrop hormone (ACTH) and β-endorphin release induced by ether stress was examined. Ether inhalation-induced ACTH and β- endorphin increase was inhibited by ICV administration of 30 μg but not 1 and 10 μg clonidine (α2-adrenoreceptor agonist). ICV oxymetazoline (α(2A)-adrenoreceptor agonist; 1-10-30 μg) or the α1-agonist methoxamine (100 μg/rat) failed to inhibit the stress-induced rise. Pretreatment with the α1/α2(2B,C)-antagonist prazosin (0.5 mg/kg, IP) prevented the effect of clonidine on the ether stress, while the α1/α(2A)-antagonist WB-4101 (0.5 mg/kg, IP) was unable to counteract the inhibitory effect of clonidine. Prazosin alone had no effect on the ether-induced plasma ACTH and β- endorphin elevation. These results suggest that noradrenaline in the central nervous system may inhibit the stress-induced hypothalamo-pituitary-axis and pituitary β-endorphin activation via α(2B,C)-adrenoceptor subtypes and prazosin may antagonize its effect on these receptors.

KW - Clonidine

KW - Ether stress

KW - Methoxamine

KW - Oxymctazoline

KW - Prazosin

KW - WB-4101

UR - http://www.scopus.com/inward/record.url?scp=0032983162&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032983162&partnerID=8YFLogxK

U2 - 10.1016/S0306-4530(98)00081-X

DO - 10.1016/S0306-4530(98)00081-X

M3 - Article

C2 - 10101737

AN - SCOPUS:0032983162

VL - 24

SP - 333

EP - 343

JO - Psychoneuroendocrinology

JF - Psychoneuroendocrinology

SN - 0306-4530

IS - 3

ER -